| |
 |
|
 |
|
|
|
|
 |
|
|
|
|
| |
| Media Releases |
| Articles for 2008 |
|
| | | August 2008 | | 25 August 2008 | | Today, approximately 172.6 million Adcock Ingram ordinary shares were listed on the Main Board of the JSE in the "Pharmaceuticals" sector, as Tiger Brands unbundled its share-holding in Adcock Ingram. Adcock Ingram’s share price at 9am was R34.05. ... more>> | | | | | 8 August 2008 | | Adcock Ingram Limited has today issued a product recall to all customers and healthcare professionals to withdraw with immediate effect two of its ARV products, Adco-Nevirapine® Tablets (Batch number 1J, expiry Jan 2009) and Adco-Zidovudine® Tablets (Batch number 1Z, expiry Nov 2008). ... more>> | | | | | July 2008 | | 9 July 2008 | Adcock Ingram is the only South African company that has invested in and successfully developed in-house a range of Antiretroviral (ARV) generic treatments, using South African expertise and local manufacturing. Today, Adcock Ingram proudly manufactures a range of 1st line adult and peadiatric ARV products at its Wadeville factory.
In 2003 Adcock Ingram engaged a highly skilled, motivated team of eight research scientists, based at Adcock Ingram’s Research and Development Facility in ... more>> | | | | | May 2008 | | 19 May 2008 | | Tiger Brands Limited today reported a 14,7% increase in headline earnings per share to 756,6 cents for the six months ended 31 March 2008 as consumer demand remained robust across most Fast Moving Consumer Goods (FMCG) categories. Earnings per share increased by 10,5% to 690,8 cents per share for the same period. ... more>> | | | | | 9 May 2008 |
Shareholders of Tiger Brands are referred to the announcement made on SENS on 22 April 2008, in which shareholders were advised that Tiger Brands had been granted a short extension of time in which to present documentation to the Competition Commission in connection with the complaint referral by the Competition Commission relating to alleged anti-competitive practices by AICC.
... more>> | | | | | March 2008 | | 19 March 2008 | Tiger Brands Limited advises that its subsidiary Adcock Ingram Critical Care (Proprietary) Limited (AICC) will file an answering affidavit as soon as is possible but no later than 28 March 2008 to the Competition Commission with regards to the complaint referral alleging anti-competitive practices at AICC. Tiger Brands advised shareholders on 12 February 2008 of the complaint referral from the Competition Commission.
Caption: Jimmy Manyi, Group Executive, Corporate Affairs
more>> | | | | | February 2008 | | 19 February 2008 | In an announcement published on 6 November 2007, Tiger Brands informed the market of its intention to unbundle and separately list Adcock Ingram on the JSE Limited by the end of March 2008. Significant progress has been made in relation to the completion of the formalities for the unbundling. However, on 11 February 2008, Tiger Brands was informed of a referral by the Competition Commission to the Competition Tribunal of a case of collusion against its subsidiary company Adcock Ingram ... more>> | | | | | 13 February 2008 | Tiger Brands Limited is devastated at allegations of collusion in Adcock Ingram Critical Care (Pty) Limited, the hospital products company in its healthcare division, and has launched an immediate and urgent independent investigation, non-executive Chairman Lex Van Vught said today.
... more>> | | | | | 6 February 2008 | There’s a wealth of artistic talent amongst our health professionals. This is clearly shown in the quality of art presented at three annual exhibitions held in Cape Town, Johannesburg and Durban. All three exhibitions take place in November each year. All receive sponsorship from Adco Generics.
Caption: National Sales Manager, Koos McLachlan is pictured with Chairman of the Adco Health Professionals’ Art Society, Dr. Geoff Melman at the 2007 exhibition. ... more>> | | | |
|
|
|
|
|
|